GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Solventum Corp (NYSE:SOLV) » Definitions » DeferredTaxAndRevenue

SOLV (Solventum) DeferredTaxAndRevenue : $563 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solventum DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Solventum's current deferred tax and revenue for the quarter that ended in Sep. 2024 was $563 Mil.

Solventum DeferredTaxAndRevenue Historical Data

The historical data trend for Solventum's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum DeferredTaxAndRevenue Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23
DeferredTaxAndRevenue
- 574.00 559.00 574.00

Solventum Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 522.00 574.00 566.00 505.00 563.00

Solventum DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Solventum's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Solventum Business Description

Traded in Other Exchanges
Address
3M Center, St. Paul, MN, USA, 55144
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.